PANews reported on October 9th that according to PR Newswire, Leap Therapeutics (NASDAQ: LPTX), a biotechnology company, announced that it has completed its previously announced private placement led by Winklevoss Capital, raising $58,888,888 in cash to launch its digital asset finance strategy. Winklevoss Capital will provide financial and strategic support to help Leap build and execute its digital asset finance strategy.
Leap Therapeutics Completes $58.88 Million Private Placement to Launch Digital Asset Finance Strategy
Share to:
Author: PA一线
This content is for informational purposes only and does not constitute investment advice.
Follow PANews official accounts, navigate bull and bear markets together
Recommended Reading
